As Western lifestyle habits extend into developing countries, so too, do the diseases which come with them.

In a paper from the World Health Organization’s International Agency for Research on Cancer (IARC) in Lyon, France the findings indicate that along with a rise in living standards, cancer will be on the rise.

A 75 percent increase in cancer by 2030 is expected in the developing world.

The researchers said that rising living standards in less developed countries would probably lead to a decrease in the number of infection-related cancers. But it was also likely there would also be an increase in types of the disease usually seen in richer countries.
They predicted that middle-income countries such as China, India and Africa could see an increase of 78 percent in the number of cancer cases by 2030.
Cases in less developed regions were expected to see a 93 percent rise over the same period, said the paper published in the journal Lancet Oncology.
Those rises would more than offset signs of a decline in cervical, stomach and other kinds of cancer in wealthier nations, said the researchers.

The most common types of cancer in the world are lung cancer, female breast cancer, colorectal cancer, stomach cancer, prostate cancer, liver cancer and cervical cancer.

TB that resists antibiotic treatment is causing problems in India.

Over crowded living conditions, poor hygiene, ill-informed medical staff are and over use of antibiotics are fueling the already rampant problem.

The risk of drug resistant disease becoming pandemic is one of the Greatest concerns of the World Health Organization.

The problem of evolving TB drug resistance has been brewing for years. In the early 1990s, multidrug-resistant TB began spreading in New York City, abetted by homelessness, prison outbreaks and HIV. Aggressive identification and treatment of these cases, including the direct observation of patients taking their pills, snuffed out that epidemic.

In 2005, extensively drug-resistant TB — strains untreatable with the three first-line drugs and several second-choice medications — cropped up in the South African province of Kwazulu-Natal, again abetted by HIV, which devastates immune defenses.

Called New Delhi metallobeta-lactamase, or NDM-1 for short, the enzyme destroys carbapenems, an important group of antibiotics used for difficult infections in hospitals, and has been found in a wide variety of bacterial types.

Although there is no threat to the U.S as of the yet, the developement of new antibiotics to fight superbugs has come to a halt.

If these bugs spread we are certainly at risk for a disaster and a threat to modern medicine as we know it.

Read the full article for all the details.

Some experts warn health-care provision is in danger of reverting back to a pre-antibiotic era in which hip replacements, care of preterm babies and advanced cancer treatment are no longer possible.

Abuse of antibiotic use in helthcare and livestock has increased superbug resistance to these therapies.